138 related articles for article (PubMed ID: 34870897)
1. Experimental Autoimmune Encephalomyelitis in the Mouse.
Laaker C; Hsu M; Fabry Z; Miller SD; Karpus WJ
Curr Protoc; 2021 Dec; 1(12):e300. PubMed ID: 34870897
[TBL] [Abstract][Full Text] [Related]
2. Experimental autoimmune encephalomyelitis in the mouse.
Miller SD; Karpus WJ; Davidson TS
Curr Protoc Immunol; 2010 Feb; Chapter 15():15.1.1-15.1.20. PubMed ID: 20143314
[TBL] [Abstract][Full Text] [Related]
3. Experimental autoimmune encephalomyelitis in the mouse.
Miller SD; Karpus WJ
Curr Protoc Immunol; 2007 May; Chapter 15():15.1.1-15.1.18. PubMed ID: 18432984
[TBL] [Abstract][Full Text] [Related]
4. Experimental autoimmune encephalomyelitis in the rat.
Swanborg RH; Stepaniak JA
Curr Protoc Immunol; 2001 May; Chapter 15():15.2.1-15.2.14. PubMed ID: 18432734
[TBL] [Abstract][Full Text] [Related]
5. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
6. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
[TBL] [Abstract][Full Text] [Related]
7. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.
Ben-Nun A; Mendel I; Bakimer R; Fridkis-Hareli M; Teitelbaum D; Arnon R; Sela M; Kerlero de Rosbo N
J Neurol; 1996 Apr; 243(4 Suppl 1):S14-22. PubMed ID: 8965116
[TBL] [Abstract][Full Text] [Related]
8. Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor.
Badawi AH; Siahaan TJ
J Neuroimmunol; 2013 Oct; 263(1-2):20-7. PubMed ID: 23911075
[TBL] [Abstract][Full Text] [Related]
9. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
10. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
Lyons JA; Ramsbottom MJ; Cross AH
Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
[TBL] [Abstract][Full Text] [Related]
11. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif.
Amor S; O'Neill JK; Morris MM; Smith RM; Wraith DC; Groome N; Travers PJ; Baker D
J Immunol; 1996 Apr; 156(8):3000-8. PubMed ID: 8609422
[TBL] [Abstract][Full Text] [Related]
12. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
Yu M; Johnson JM; Tuohy VK
J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
[TBL] [Abstract][Full Text] [Related]
13. Induction of autoimmune encephalomyelitis and uveitis in B6 and (B6 x SJL) mice by peptides derived from myelin/oligodendrocyte glycoprotein.
Shao H; Sun SL; Kaplan HJ; Sun D
J Neuroimmunol; 2002 Nov; 132(1-2):117-22. PubMed ID: 12417441
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
16. A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis.
Bäckström BT
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36571423
[TBL] [Abstract][Full Text] [Related]
17. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
18. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice.
Fritz RB; Zhao ML
J Neurosci Res; 1996 Aug; 45(4):471-4. PubMed ID: 8872908
[TBL] [Abstract][Full Text] [Related]
19. Titration of myelin oligodendrocyte glycoprotein (MOG) - Induced experimental autoimmune encephalomyelitis (EAE) model.
Aharoni R; Globerman R; Eilam R; Brenner O; Arnon R
J Neurosci Methods; 2021 Mar; 351():108999. PubMed ID: 33189793
[TBL] [Abstract][Full Text] [Related]
20. Experimental Autoimmune Encephalomyelitis of Mice: Enzymatic Cross Site-Specific Hydrolysis of H4 Histone by IgGs against Histones and Myelin Basic Protein.
Urusov AE; Aulova KS; Dmitrenok PS; Buneva VN; Nevinsky GA
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
